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Abstract
Activation-induced deaminase (AID) initiates somatic hypermutation, gene conversion and class switch recombination by
deaminating variable and switch region DNA cytidines to uridines. AID is predominantly cytoplasmic and must enter the
nuclear compartment to initiate these distinct antibody gene diversification reactions. Nuclear AID is relatively short-lived,
as it is efficiently exported by a CRM1-dependent mechanism and it is susceptible to proteasome-dependent degradation.
To help shed light on mechanisms of post-translational regulation, a yeast-based screen was performed to identify AID-
interacting proteins. The calcium and integrin binding protein CIB1 was identified by sequencing and the interaction was
confirmed by immunoprecipitation experiments. The AID/CIB1 resisted DNase and RNase treatment, and it is therefore
unlikely to be mediated by nucleic acid. The requirement for CIB1 in AID-mediated antibody gene diversification reactions
was assessed in CIB1-deficient DT40 cells and in knockout mice, but immunoglobulin gene conversion and class switch
recombination appeared normal. The DT40 system was also used to show that CIB1 over-expression has no effect on gene
conversion and that AID-EGFP subcellular localization is normal. These combined data demonstrate that CIB1 is not required
for AID to mediate antibody gene diversification processes. It remains possible that CIB1 has an alternative, a redundant or a
subtle non-limiting regulatory role in AID biology.
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Introduction
Following V(D)J recombination, the expressed antibody reper-
toire in vertebrate B lymphocytes gains additional diversity
through the processes of immunoglobulin (Ig) gene conversion
(IGC), somatic hypermutation (SHM), and class-switch recombi-
nation (CSR) (reviewed by [1–3]). Most vertebrates use SHM to
diversify variable (V) region sequences, but a few species, such as
birds and rabbits, use a template-dependent IGC mechanism to
generate antigen-binding diversity and improve antibody affinity.
All vertebrates use CSR to irreversibly change the constant (C)
region of the heavy chain Ig gene, which dictates the antibody
tissue distribution and function.
All three of these antibody gene diversification reactions are
initiated at the DNA level by activation-induced cytidine
deaminase (AID)-catalyzed deoxy-cytidine to deoxy-uridine edit-
ing ([4]; reviewed by [1–3]). Once these lesions occur in Ig gene
DNA, ubiquitious DNA ‘repair’ enzymes catalyze further
reactions that ultimately result in the distinct outcomes described
above. For instance, both the uracil DNA glycosylase UNG2 and
the mismatch recognition proteins MSH2/6 help process AID-
catalyzed DNA uridines [5–7].
Several lines of evidence indicate that AID is subject to
numerous levels of post-translational regulation. First, AID is
predominantly cytoplasmic, and recent data suggest that this may
occur through an active retention mechanism [8–10]. Second,
AID is actively imported into the nuclear compartment, a step that
is undoubtedly required for its essential role in antibody gene
diversification [10,11]. Third, AID is exported from the nuclear
compartment by virtue of a carboxy-terminal leucine-rich motif,
which is bound by CRM1 and necessary for export [9–13].
Fourth, AID is susceptible to post-translational regulation by
ubiquitination and phosphorylation [14–20]. The responsible E3
ubiquitin ligation complex has yet to be identified, but protein
kinase A (PKA) has been shown to phosphorylate AID [14,16,18].
Finally, phosphorylation enhances the interaction between AID
and replication protein A, which may be an important DNA level
co-factor [21]. These studies combine to indicate that multiple
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identified.
To gain further insights into the proteins that regulate AID, we
used high-throughput yeast two-hybrid screening to identify
interacting proteins. We found that AID interacts with the
calcium and integrin binding protein 1 (CIB1), a 22 kDa
regulatory protein that is broadly expressed, comprised of four
EF hand motifs (two of which bind calcium), and required for
spermatogenesis in mice [22,23]. CIB1 is a provocative AID-
interacting protein, because it could potentially link B cell receptor
signaling, activation through calcium fluctuations, and the
germinal center specific antibody gene diversification reactions.
The requirement for CIB1 in AID-mediated processes was
examined in two model systems for antibody gene diversification,
the chicken B cell line DT40 and murine B lymphocytes.
Results
The AID-CIB1 interaction
A large scale, Gal4-based yeast two-hybrid screen was
conducted as described [24]. A bait plasmid expressing human
AID residues 56–198 was used to screen a tongue and tonsil cDNA
library. DNA sequencing was used to identify candidate
interactors, and false positives were eliminated by cross checking
literature, public databases, and unpublished data. Only one
positive hit resisted triage: residues 1–191 of the calcium and
integrin binding protein 1 (CIB1). Other reported AID-interaction
proteins, DNA-PKcs [25], MDM2 [26], RPA [21], PKA [14,18],
and CTNNBL1 [27], were not recovered.
To confirm the yeast two-hybrid result, we co-expressed AID-
EGFP and myc-CIB1 in HEK-293T cells and asked whether the
two proteins interacted by co-immunoprecipitation (co-IP). These
experiments showed that myc-CIB1 was able to co-IP AID-EGFP
(Fig. 1A). In contrast, myc-CIB1 did not co-IP an EGFP control.
AID can bind single-stranded nucleic acids, including both
DNA and RNA [28]. AID homologs such as APOBEC3G also
bind RNA, and this interaction enables indirect associations with
many different cellular proteins [29–33]. To ask whether the AID-
CIB1 interaction occurs through a nucleic acid bridge, co-IP
experiments were repeated in the presence of DNase or RNase.
An a-GFP (AID) IP resulted in strong myc-CIB1 immunoblot
signals, which were not diminished by incubating extracts with
either DNase I or RNase A (Fig. 1B). These data strongly
suggested that the interaction between AID and CIB1 occurs
independently of a nucleic acid bridge.
To further substantiate the AID-CIB1 interaction, a pull-down
experiment was performed with a tandem affinity purification
construct AID-STZ (Materials and Methods). This construct, or
an EGFP-STZ control, was transfected into HEK-293T cells,
expressed for 48 hours, and ultimately pulled-down with IgG
Sepharose, which binds the Z domain of Protein A. Immunoblot-
ting with a CIB1-specific monoclonal antibody revealed that
endogenous CIB1 associates with AID-STZ but not with EGFP-
STZ, which was even more highly expressed (Fig. 1C).
CIB1 over-expression in DT40
To begin to test whether CIB1 regulates AID-dependent
antibody gene diversification reactions, we over-expressed both
human and chicken CIB1 proteins in the chicken B cell line DT40.
This cell line constitutes a good model system for studying IGC,
because the reversion of an Ig frameshift mutation is AID-
dependent and can be monitored at the cellular level by flow
cytometry of surface Ig positive cells [34,35]. CIB1 over-expressing
lines were established and subjected to limiting dilution, and 8–12
of the resulting subclones were cultured continuously for 6 weeks.
The median percentage of surface Ig positive cells among the
control vector transfected subclones was 7.5%, and the medians of
the CIB1 over-expressing subclones were not significantly different
(Fig. 2). These data indicated that CIB1 protein levels are not
limiting in DT40 for gene conversion at the antibody locus.
Immunoglobulin gene conversion in CIB1 knockout DT40
To determine whether CIB1 is required for IGC in DT40, serial
gene targeting was used to delete exons 5 and 6 of the CIB1 gene
(Fig. 3A). A linearized targeting vector encoding the puromycin-
resistance gene was transfected into a surface Ig-negative DT40
line and resistant colonies were isolated. Gene targeting events
were identified by PCR (Figs. 3A & B). CIB1 heterozygous lines
were subjected to a second round of gene targeting with a
blasticidin resistance construct. CIB1 null lines were identified by
allele-specific PCR reactions and confirmed by reverse-transcrip-
tion PCR and Southern blot analyses (Figs. 3B & C and data not
shown). The CIB1 defective cells showed no obvious growth
defects or cellular abnormalities demonstrating that this protein is
not essential in DT40 cells.
Figure 1. AID interacts with the calcium and integrin binding protein 1. A. myc-CIB1 co-IPs AID-EGFP but not EGFP only (left and right lanes,
respectively). A myc-specific monoclonal antibody was used to precipitate complexes, and AID-GFP was detected with an a-GFP polyclonal antibody.
B. AID-EGFP co-IPs myc-CIB1 in a DNase I- and RNase A-resistant manner. An a-GFP monoclonal antibody was used to precipitate AID-GFP, and myc-
CIB1 was detected with an a-myc monoclonal antibody. C. AID-STZ pulls down endogenous CIB1 from HEK-293T cell extracts. IgG Sepharose was
used to pull-down STZ complexes, and CIB1 was detected using an a-CIB1 polyclonal antibody. AID-STZ and GFP-STZ were detected with an a-strep
antibody. A low level of non-specific background was observed in the vicinity of AID-STZ. For cell lysate (input) control blots, two panels are shown
because GFP-STZ is expressed over 100-fold better than AID-STZ. A quantification of the input versus pull-down signal indicated that 1% of cellular
CIB1 can be pulled-down with AID complexes when IgG sepharose beads are limiting.
doi:10.1371/journal.pone.0011660.g001
AID and CIB1 Interaction
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negative CIB1
+/+,C I B 1
+/2,a n dC I B 1
2/2 cell lines were subcloned
by limiting dilution, maintained in culturefor 6 weeks, labeled with a-
Ig antibody, and quantified by flow cytometry. We found that the
median frequency of surface Ig-positive subclones was nearly identical
for CIB1
+/+,C I B 1
+/2,a n dC I B 1
2/2 cell lines, 4.5%, 3.9%, and
4.4%, respectively (Fig. 3D). These data provided an unambiguous
demonstration that CIB1 is not required for IGC in DT40.
AID localization in CIB1 knockout DT40
Another property of AID is that it localizes predominantly to
the cytoplasm of cells (e.g., [8–10,36]). To ask whether CIB1 is
required for this process, we stably transduced wildtype and CIB1-
deficient DT40 cells with an AID-EGFP expression construct and
used fluorescent microscopy to image the resulting localization
patterns (Fig. 4). The cytoplasmic localization of AID-EGFP was
indistinguishable in wildtype and CIB1-deficient cells indicating
that CIB1 is also dispensable for this property.
Isotype switching in CIB1 knockout mice
To evaluate the potential contribution of CIB1 to another AID-
dependent process in another model organism, we examined the
CSRphenotypeof CIB1-deficientmice[23]. First,we measuredthe
abundance of alternative antibody isotypes in sera from 3 wildtype
and 6 CIB1-deficient mice by ELISA (Fig. 5A). Normal levels of
IgM, IgG1, IgG2a, IgG2b, IgG3, and IgA were observed indicating
that a CIB1 deficiency does not result in a gross CSR defect.
However, minor deficiencies in CSR can be readily eclipsed by
antigen driven clonal expansions of alternative isotype expressing
B lymphocytes. We therefore next examined the capacity of
wildtype and CIB1-deficient primary B lymphocytes to undergo
CSR ex vivo in response to lipopolysacharride (LPS) and
interleukin-4 (IL-4) treatment. This stimulatory regimen drives
CSR from IgM to IgG1, which is easily quantified by anti-IgG1
staining and flow cytometry (e.g., [5]). After 4 days in culture, 28%
of the wildtype cells expressed surface IgG1 and near-identical
results were obtained with CIB1-deficient B lymphocytes (Fig. 5B).
These data combined to demonstrate that CIB1 is not required for
CSR in mice or in murine B lymphocytes ex vivo.
Germinal center morphology in CIB1 knockout mice
AID-deficient mice have enlarged germinal centers and
spleenomegaly [37]. To ask whether the CIB1 interaction with
AID may be important for proper development in vivo,w e
compared the morphology of the spleens of wildtype and CIB1-
deficient mice. Spleens were removed, sectioned, and stained with
hematoxylin and eosin. CIB1-deficient mice were found to have a
normal spleen and germinal center morphology (Fig. 5C).
Discussion
AID-mediated antibody diversification reactions are conserved
processes in vertebrates. However, the precise mechanisms that
regulate AID remain to be fully understood. We identified the
calcium and integrin binding protein 1 (CIB1) as a strong AID-
interacting protein. This protein is an attractive regulatory
candidate because calcium signaling is an integral part of antigen-
dependent adaptive immune responses. However, the complete
ablation of CIB1 in DT40 or mice demonstrated that this protein is
dispensable for both IGC and CSR in these organisms (i.e., CIB1 is
not an antibody diversification co-factor). Moreover, the lack of any
detectable antibody diversification phenotype also indicated that
CIB1isunlikelytobeacriticalpositiveornegative regulatorofAID.
This point was further underscored by the lack of an Ig
diversification phenotype in CIB1 over-expressing DT40.
CIB1 is however important for other functions in vertebrates. It
is a nonenzymatic regulatory molecule that binds an array of
target proteins and modulates their activity. For example, CIB1
activates the serine/threonine kinase p21-activated kinase (PAK1)
and thereby modulates the migratory and proliferative capacities
of cells [38]. It inhibits polo-like kinase 3 (PLK3), which may slow
the G1 phase of the cell cycle [39], and it inhibits apoptosis signal-
regulating kinase (ASK1), which negatively regulates the stress-
activated MAP kinases JNK and p38 [40]. The CIB1 knockout
mouse develops near normally under non-stressed conditions
except that the CIB12/2 male is sterile [23]. This is most likely
due to a disrupted progression of the haploid phase of
spermatogenesis. Significantly slowed proliferation of mouse
embryo fibroblasts was also noted. While the exact cause of the
disrupted haploid phase is unclear, it may be related to elevated
levels of the cell cycle regulator CDC2/CDK1.
Since the interaction between AID and CIB1 is robust, we were
surprised that antibody gene diversification reactions are not
obviously affected. This could be due to a functional overlap
between CIB1 and the related calcium and integrin binding
proteins, CIB2 and CIB3, which share over 60% amino acid
similarity [22,41]. However, AID may have other roles in the
biology of vertebrates, such as the provision of innate immunity to
retrotransposition [36,42–44], the restriction of foreign DNA [45],
or the epigenetic reprogramming of stem cells [46,47]. Future
studies will be necessary to address the role of CIB1 in these
potentially interesting alternatives.
Materials and Methods
Ethics Statement
All experimental procedures for working with mice, described in
full below, were approved by the University of Minnesota
Figure 2. CIB1 over-expression in DT40. A. An IGC fluctuation
analysis showing the percentage of surface Ig-positive cells in subclone
cultures over-expressing human (h) or chicken (c) CIB1. Each X
represents data from an individual subclone and the labeled horizontal
bars report the medians for each data set. B. CIB1 over-expression
confirmed by immunoblotting. Loading was controlled by stripping and
re-probing the blot with an a-tubulin antibody.
doi:10.1371/journal.pone.0011660.g002
AID and CIB1 Interaction
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Number: 0703A04446).
DNA constructs
The parental myc expression vector encoding 6 copies of an N-
terminal myc tag was a generous gift from Dr. Shigeki Miyamoto
(University of Wisconsin) [48]. Human CIB1 cDNA was PCR
amplified from a spleen cDNA library (Invitrogen) using primers 59-
GAA-TTC-TGA-TGG-GGG-GCT-CGG-GCA-GTC-GC and 59-
CTC-GAG-TCA-CAG-GAC-AAT-CTT-AAA-GGA-GCT-G, di-
gested with EcoRI/XhoI and ligated into p6xmyc to generate
p6xmyc-hCIB1. Chicken CIB1 cDNA was PCR amplified from
DT40 cDNA using primers 59-GAA-TTC-TCA-TGG-GGG-GCT-
CCA-GCA-GTC-TGC and 59-CTC-GAG-TCA-CAG-GAC-AAT-
CTT-GAA-GG, digested with EcoRI/XhoI, and ligated into p6xmyc
to generate p6xmyc-cCIB1.
Human AID cDNA [26] was PCR amplified using primers 59-
TAA-TAC-GAC-TCA-CTA-TAG-GG and 59-GTC-GAC-AAG-
TCC-CAA-AGT-ACG-AAA-TGC, digested with HindIII/SalI,
and ligated into similarly cut pEGFP-N3 (Clontech). The lentiviral
transduction vector pCSII-AID-EGFP was generated by directly
subcloning AID-EGFP from pEGFP-N3-AID into pCSII-EF-
MCS [49] using the XhoI/NotI sites. The lentiviral packaging and
helper plasmids pMDG and DNRF were provided by Dr. Nik
Somia (University of Minnesota) [50,51].
The tandem affinity purification constructs,pAID-STZ and pEGFP-
STZ (Strep, TEV, Z domain), were made as follows. First, a Tobacco
Etch Virus (TEV) protease cleavage site (ENLYFQG) was cloned into
Figure 3. CIB1 is dispensable for immunoglobulin gene conversion in DT40. A. Schematic showing the constructs used to replace exons 5
and 6 of CIB1 with the indicated drug resistance cassettes. The positions of the allele-specific PCR primers for genotyping and the XhoI sites and the
position of the 39 external probe used for Southern blot analysis are shown. B. An agarose gel image showing the allele-specific PCR products from
CIB1+/+, +/2, and 2/2 cell lines. C. An agarose gel image of CIB1-specific RT-PCR products from CIB1+/+, +/2, and 2/2 cell lines. AID-specific
reactions were used to demonstrate the integrity of each cDNA preparation. D. An IGC fluctuation analysis showing the percentage of surface Ig-
positive cells in subclone cultures of the indicated genotype. Each X represents data from an individual subclone and the labeled horizontal bars
report the medians for each data set.
doi:10.1371/journal.pone.0011660.g003
Figure 4. AID localization in CIB
2/2 DT40 cells. A. AID-EGFP
localization in CIB1
+/+ DT40. B. AID-EGFP localization in CIB1
2/2 DT40.
Images were taken using a 406objective and the scale bars indicate 10 mm.
doi:10.1371/journal.pone.0011660.g004
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tandem copies of the IgG binding Z domain of protein A were
amplified by PCR from pRAV-flag [52] using primers 59-CCC-GGG-
ATG-AGG-TTA-ACC-ATG-GCG-CAA and 59-GAG-CTC-TCT-
AGA-TTA-CGC-GTC-TAC-TTT-CGG-CGC-CTG and cloned
into SacI/SmaI sites of pBluescript-TEV. Third, a XhoI-NotI-EcoRI
linker was added by ligating annealed primers 59-TCG-AGA-GCG-
GCC-GCA-TG and 59-AAT-TCA-TGC-GGC-CGC-TC into the
XhoI/EcoRI sites. Fourth, a Streptavidin tag was added by ligating
annealed oligonucleotides 59-GGC-CGC-ATG-GCT-AGC-TGG-
AGC-CAC-CCG-CAG-TTC-GAA-AAA-GGC-GCC and 59-GGC-
CGG-CGC-CTT-TTT-CGA-ACT-GCG-GGT-GGC-TCC-AGC-
TAG-CCA-TGC into the NotI site. Fifth, Strep-TEV-ZZ was
subcloned into the XhoI/XbaI sites of pcDNA3.1(Invitrogen). Finally
human AID or EGFP were subcloned into KpnI/SalI sites of this
construct to generate pAID-STZ and pEGFP-STZ.
The chicken CIB1 targeting vectors were generated by
amplifying targeting arms from DT40 genomic DNA using
primers 59-GGC-CCG-TTT-TCG-TCC-CCC-GGA and 59-
ACG-GCA-CCT-CCG-TGC-GGG-AGC (1.2 kb left arm) and
59-TCC-AGC-AGC-ATA-AGG-GGT-CCC and 59-CTG-CAC-
AGA-GCT-CGT-TCC-CCA (1.0 kb right arm). These PCR
products were cloned into pCR-BluntII-TOPO (Invitrogen) and
subcloned into pBluescript II KS+ (Stratagene) using NotI/
BamHI (left arm) and EcoRI/HindIII (right arm). The puromycin
or blasticidin resistance cassettes were then subcloned from bML4
or bML5 [34] into the BamHI site between the homology arms.
Immunoprecipitation experiments
HEK-293T cells [32,38] were transfected with 5 mg of plasmid
pEGFP-N3-AID or pEGFP-N3 and p6xmyc-CIB1 in a 10 cm
dish (,60% confluent) using a ratio of 1 mg DNA to 3 ml
FuGene6 (Roche). 48 hrs post-transfection, cells were treated
with 50 mM MG132 for 5 hours prior to harvesting. MG132 was
included to minimize the degradation of AID by the proteasome
[19], although it was not necessary to detect the AID/CIB1
interaction (data not shown). The cells were washed in cold PBS
and resuspended in lysis buffer [25 mM HEPES, pH 7.4;
150 mM NaCl; 1 mM EDTA; 1 mM MgCl2; 1 mM ZnCl2;
10% glycerol; 1% NP40; protease inhibitors (Complete, EDTA-
free, Roche)], on a rotating wheel for 1 hour at 4uC. The lysate
was clarified by centrifugation at 13,000 g for 20 minutes and
300 ml was incubated with 2.5 mL( 2 . 5mg) a-myc mAb (LabVi-
sion) on a rotating wheel for 30 minutes at 4uC before the
addition of 25 mL of pre-washed Protein G Sepharose (GE
Healthcare). Bound complexes were washed three times with lysis
buffer and once with TBS/0.05% Tween 20. Proteins were
eluted off the beads with 0.1 M glycine (pH 2.5) and resolved by
10% SDS-PAGE. The proteins were transferred to PVDF
membrane and blotted with a rabbit a-GFP polyclonal Ab
(Invitrogen) to detect AID-GFP.
Reciprocal pulldowns were conducted by transfecting pEGFP-
N3-AID or pEGFP-N3 and 6xmyc-hCIB1 as above. Lysates
(300 mL) were incubated with 20 mg of RNase A, DNase I or BSA
at 37uC for 20 minutes (Sigma). They were then incubated with
5 mL( 5mg) of a-GFP mAb (Clontech JL8) on a rotating wheel for
30 minutes at 4uC before the addition of 25 mL of washed Protein
G Sepharose beads. The beads were washed, eluted, and
transferred as above then blotted with a-myc (LabVision 9E11
mAb).
For the endogenous CIB1 pull-down experiments, HEK-293T
cells were transfected as above with pAID-STZ or pEGFP-STZ.
These proteins were precipitated with IgG Sepharose (GE
Healthcare), removed from beads by TEV protease cleavage,
processed as above to a PVDF membrane, and probed first with
an a-CIB1 monoclonal antibody [53] and second with an a-Strep
monoclonal antibody (Novagen). Primary antibodies were detect-
ed with a-rabbit-HRP or a-mouse-HRP secondary reagents
(BioRad).
DT40 experiments
Surface Ig-negative DT40 cells were maintained in RPMI
(Hyclone) supplemented with 10% FBS (Gibco) and 50 mM2 -
mercaptoethanol. Cells were subcloned by limiting dilution and
grown continuously for 6 weeks. The IGC capacity was
determined by measuring the percentage of cells that reverted to
surface Ig-positive by staining with R-PE conjugated mouse a-
chicken Ig antibody (Southern Biotechnology Associates, Inc.) and
quantifying labeled cells by flow-cytometry (FACSCalibur, BD
Biosciences). 8–12 independent subclones were examined for each
condition and the median percentage of surface Ig-positive cells
was used to assess gene conversion capacity.
Figure 5. CIB1 is dispensable for CSR in mice. A. Relative levels of each antibody isotype in sera from CIB1
+/+ or CIB1
2/2 mice as measured by
ELISA. The CIB1
2/2 data were normalized to the mean antibody levels in sera from wildtype (WT) littermates (arbitrarily set to 1 for comparison). Each
X represents data from an independent animal and the horizontal bars and labels report the median values (n=3 for CIB
+/+ and n=6 for CIB
2/2). B.
IgM to IgG1 CSR ex vivo. B-cells were isolated from the spleens of CIB1
+/+ or CIB1
2/2 mice, cultured for 4 days in the presence of LPS and IL-4, and
analyzed by a-IgG1-PE labeling and flow cytometry. Each X represents data from an independent animal and the horizontal bars and labels report the
median values. C. Images of hematoxylin and eosin stained sections of spleen isolated from CIB1
+/+ and CIB1
2/2 mice. Scale bars indicate 500 mm.
doi:10.1371/journal.pone.0011660.g005
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[26,35]. Targeting constructs were linearized with NotI and
electroporated into 20 million cells (500 V, 25 mF; BioRad
GenePulser II). Following the appropriate drug selection
(0.25 mg/ml puromycin, 10 mg/ml blasticidin), single clones were
isolated and expanded for screening by PCR, RT-PCR, and
Southern blotting. For PCR screening, a common reverse
primer 59-CTT-TGT-GCC-TCC-CGT-TAG-AG located 39 to
the targeting arm was used in combination with forward primers
designed specifically for exon 5 59-GAT-GGC-ACC-ATC-AAC-
CTC-TC, the blasticidin drug cassette 59-GAA-GAC-CCC-AAG-
GAC-TTT-CC, or the puromycin cassette 59-CCC-CCT-GAA-
CCT-GAA-ACA-TA. To confirm loss of CIB1 mRNA expression,
cDNA was generated from total mRNA and subjected to RT-PCR
using primers spanning intron 4 59-GGG-ATG-ACA-GCA-TGT-
CCT-TT and 59-TGA-GCT-GCT-CCA-TCT-CAA-TG. Prim-
ers for AID expression were used to verify the presence of cDNA
59-TGG-ACA-GCC-TCT-TGA-TG and 59- GTC-CCA-GAG-
TTT-TAA-AG. For Southern blotting, a 39 probe was generated
by PCR from DT40 genomic DNA using primers 59-GAT-CCC-
TCC-CTC-CTT-GGG-AGA and 59-CCG-GAG-GCG-TTG-
GCT-GGT-GCC.
DT40 lines stably expressing chicken CIB1 or human CIB1
were generated by electroporating linearized (BglII) p6xmyc-
hCIB1 or p6xmyc-cCIB1 (250 V, 950 mF, 2 pulses; BioRad
GenePulser II) into surface Ig negative DT40, selecting with
1.5 mg/ml Geneticin (Invitrogen), and screening for expression by
immunoblotting. 2610
6 cells were lysed in NP40 lysis buffer
[25 mM HEPES, pH 7.4; 150 mM NaCl; 1 mM EDTA; 1 mM
MgCl2; 1 mM ZnCl2; 10% glycerol; 1% NP40; protease inhibitors
(Complete, EDTA-free, Roche)] on ice for 1 hr and then clarified
by centrifugation (16,100 g, 5 min). The supernatants were
denatured in Laemmli loading buffer and separated by SDS-
PAGE. Proteins were transferred to PVDF membrane and blotted
with a-myc (LabVision 9E11 mAb) to detect transfected CIB1 or
a-tubulin (Covance mAb).
AID localization was determined in DT40 by transducing cells
with a lentivirus encoding AID-EGFP (above). Lentiviruses were
produced by transfecting HEK-293T cells with pCSII-AID-EGFP,
the VSV-G envelope vector pMDG, and the DNRF packaging
construct encoding the HIV-1 gag, pol, rev, tat, and vpu genes as
described previously [51]. DT40 cells were cultured in lentiviral
supernatant for 12 hrs to enable viral transduction. After an
additional 36 hrs, the cells were washed with fresh media and
AID-EGFP localization was determined by fluorescence micros-
copy (406objective; Deltavision).
Mouse experiments
Experimental procedures were conducted in accordance with
the University of Minnesota Institutional Animal Care and Use
Committee guidelines. The CIB1-deficent mice were reported
previously [23]. Heterozygous mice were bred to produce
experimental wildtype and CIB1-deficient littermates, which were
housed approximately 7 weeks and then used for experiments.
To quantify serum Ig levels, 50–100 ml blood was collected from
mice via facial vein bleeding and allowed to clot at room
temperature. After removing cells by centrifugation, serum
antibody titers for isotypes IgM, IgG1, IgG2a, IgG2b, IgG3, and
IgA were determined by ELISA using a Mouse Immunoglobulin
Isotyping Kit (BD Pharmingen).
To determine the frequencies of ex-vivo CSR, resting B-cells
were isolated from dissociated spleen through magnetic sorting by
negative selection using an antibody cocktail against CD43 (Ly-
48), CD4 (L3T4), and Ter-119 (Miltenyi Biotech). Isolated B-cells
shown to be over 90% CD19 positive were then cultured for in
RPMI media (Gibco) supplemented with 10% FBS plus 50 ng/ml
IL-4 (R&D Systems) and 50 mg/ml LPS (Sigma). After 4 days, cells
were analyzed for CSR by flow-cytometry using a a-IgG1-PE
antibody (BD Biosciences).
For histology experiments, spleens were removed from eutha-
nized animals, preserved in 10% phosphate-buffered formalin,
sliced into 10 mm thick sections (Leica Instruments), stained with
hematoxylin and eosin, and examined by light microscopy to
identify germinal centers (Zeiss Axiovert).
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